Thermo Fisher Scientific Releases Corporate Social Responsibility Report

Report highlights progress toward environmental, social and governance objectives WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders providing detailed insight into the company’s CSR progress and environmental, social and governance... Read more

Bruker Corporation to Present at Jefferies 2022 Global Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will present at the Jefferies 2022 Global Healthcare Conference in New York on Thursday, June 9, 2022 at 3:00 pm EDT. Presenting for the company will be Frank Laukien, President and Chief Executive Officer, and Justin Ward, Sr. Director, Investor Relations & Corporate Development. A... Read more

PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing

Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass. – May 16, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.... Read more

Bruker Announces Quarterly Dividend

BILLERICA, Massachusetts–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on June 17, 2022 to stockholders of record as of June 1, 2022. About Bruker Corporation... Read more

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

Consortium aims to speed the development and delivery of customized or ‘bespoke’ gene therapies WASHINGTON, May 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene... Read more

Bruker and TOFWERK Form Strategic Partnership in High-Speed, Ultra-Sensitive Solutions for Applied and Industrial Markets

Compact, fast time-of-flight mass spectrometers by TOFWERK optimized for small molecule applications Innovative, on-line chemical ionization techniques for high sensitivity and in situ small molecule detection for stationary and mobile analysis Sensitive, real-time TOF-MS solutions for semiconductor applications, ambient air analysis, cork analysis and diagnostics research from exhaled breath THUN, Switzerland–(BUSINESS WIRE)– Bruker Corporation and... Read more

Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets

Maxwell™ Preclinical MRI Magnets Do Not Require Liquid Helium, Facilitate Siting LONDON–(BUSINESS WIRE)– At the ISMRM 2022 conference, Bruker today announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio. Following the success of its BioSpec® Maxwell 3 Tesla model, the new... Read more

Danaher To Present At Bank Of America Securities Health Care Conference

WASHINGTON, May 4, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 11, 2022 at 10:00 a.m. PT. The audio will be simultaneously webcast on www.danaher.com.  ABOUT DANAHERDanaher... Read more